Sigma Healthcare shares have slumped after the pharmaceuticals supplier revealed a slump of more than 50 per cent in first-half profit to $13.4 million, partly due to restructuring costs following the loss of its contract to supply Chemist Warehouse in July.
Sigma, which owns pharmacy brands Amcal, Guardian, Discount Drug Store, and Chemist King, says net profit for the six months to July 31 fell 51.8 per cent after $6.1 million of restructuring costs.
A two per cent fall in revenue to $1.96 billion was attributed to falling sales in Hepatitis C medication, and the continued impact of the rescheduling of codeine as a prescription-only drug.
Pricing adjustments to the Pharmaceutical Benefits Scheme in February, which has generally made suppl…
Read the full article at: https://www.news.com.au/finance/business/breaking-news/sigma-hy-profit-more-than-halves-to-134m/news-story/59334cca231716c84d5dfb8a330de33f